Conventional wound healing is unproductive in healing acute wounds such as deep cuts, burn injuries, and chronic ulcers. The introduction of bioactive wound care products has efficiently provided a solution to treat such critical wounds and injuries. Bioactive wound dressings control infection, hasten the healing process, reduce the risk of leakage, and alleviate pain and discomfort. Materials such as chitosan, alginates, keratin, hydrocolloids, and collagen are often the key constituents of bioactive wound dressings. Bioactive wound care is a new, yet flourishing market, where phenomenal demand for these products is being witnessed across both developed and developing markets.
In the overall bioactive wound dressings market, the demand for antimicrobial wound dressings is currently the highest due to their ability to fight infections and thus hasten the healing process. Antimicrobial dressings are being widely used in burn treatment. Some of the most common antimicrobial dressings used are silver-coated dressings and cadexomer dressings. Novel antimicrobial products, including activated charcoal and polyhexamethylene biguanide hydrochloride, serve better for patients allergic to silver. Hence, growing adoption of antimicrobial dressings will drive the overall market for bioactive wound dressings. Some other prominent drivers of this market include the augmenting senescent patient pool and the high prevalence of diabetic ulcers. Negative pressure wound dressings, semi-permeable, transparent, and foam dressings are the chief competitors to bioactive wound care products.
The global bioactive wound care market is segmented on the following bases:
Product Type
Alginates
Antimicrobial dressings
Hydrocolloids
Skin substitutes
Growth factors
Geography
North America
U.S.
Canada
Europe
Germany
France
Italy
U.K.
Russia
Rest of Europe
Asia-Pacific
India
China
Japan
Rest of Asia-Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
GCC Countries
South Africa
Rest of Middle East and Africa
Key players identified for the bioactive wound dressings market include, but are not limited to:
Covidien plc, Coloplast A/S, Paul Hartmann AG, Systagenix Wound Management Ltd., Organogenesis, Inc., Covalon Technologies, and several others
This report offers:
An overview of the global markets for bioactive wound care
Market trends assessment for the period 2013-2023, with historical information for 2013 and 2014 and projections through 2023, with respective CAGRs during 2016 and 2023
Qualitative assessment tools such as market drivers, challenges, future prospects, major commercial events, etc.
Market competition scrutiny tools such as market share analysis, an attractive investment proposition, and Porter’s Five Forces model
Focus on each level of market segmentation based on product approvals, launches, and current and anticipated market dynamics.
A general overview of the industry structure
Company profiles highlight key information about the major players operating in the bioactive wound care market.
Frequently Asked Questions:
The market for Bioactive Wound Care Market is expected to reach US$ XX Mn In 2023.
The Bioactive Wound Care Market is expected to see significant CAGR growth over the coming years, at XX%
The report is forecasted from 2023.
The base year of this report is 2022.
Covidien plc, Coloplast A/S, Paul Hartmann AG, Systagenix Wound Management Ltd., Organogenesis, Inc., Covalon Technologies, and several others are some of the major players in the global market.
